Follow our progress.

Milestones in our journey to reinvent genetic testing.

Press Releases

Invitae completes $40 million series E financing

Invitae completes $40 million series E financing

December 10, 2013

SAN FRANCISCO, December 10, 2013 - Invitae Corporation, a genetic diagnostics company, today announced the completion of a $40 million Series E financing. Invitae will use the financing to accelerate the ongoing development of the company’s clinical genetic tests for hereditary disorders, including oncology, neurology and pediatric medicine. Invitae will also focus on expanding to international markets.

Investors participating in the Series E round include Genomic Health, Inc. (NASDAQ: GHDX), Randy Scott, Thomas McNerney & Partners, Redmile Group, Genesys Capital, Casdin ...

Read more


Invitae files suit against Myriad Genetics

Invitae files suit against Myriad Genetics

December 02, 2013

SAN FRANCISCO, December 2, 2013 – Invitae Corporation, a genetic diagnostics company, today announced that it filed an action in the U.S. District Court for the Northern District of California against Myriad Genetics, Inc. (NASDAQ: MYGN).  By its suit, Invitae seeks a declaration that certain Myriad patents relating to the BRCA1, BRCA2 and MUTYH genes are invalid and are not infringed by Invitae. 

Invitae’s announcement today reinforces its commitment to defend its right to provide naturally occurring ...

Read more


Invitae responds to Myriad Genetics lawsuit

Invitae responds to Myriad Genetics lawsuit

November 26, 2013

SAN FRANCISCO, November 26, 2013 – Invitae Corporation, a genetic diagnostics company, today announced that it plans to defend its right to provide naturally occurring genetic information and services to physicians for their cancer patients through its genetic testing services.  Invitae has been named a defendant in a lawsuit filed by Myriad Genetics, Inc. regarding Invitae’s BRCA and MUTYH genetic tests. Invitae disagrees with the allegations of the lawsuit and plans to vigorously defend itself against the lawsuit, which ...

Read more


Invitae Chile, presenting the "Future of Genetic Medicine" in Santiago

Invitae Chile, presenting the "Future of Genetic Medicine" in Santiago

September 20, 2013

SANTIAGO, CHILE – September 20, 2013 - Invitae Corporation, headquartered in San Francisco, California, has announced that Genometrics, a Chilean company located in Santiago, will be the exclusive partner for the Invitae Chile SpA in Chile.  Invitae is a genetic diagnostics company specializing in genetic testing for hereditary diseases in oncology, cardiology, neurology and pediatric medicine.  Invitae previously announced that it will have a fully operational laboratory for the purpose of providing these tests for the Latin American ...

Read more


Invitae announces results of hereditary breast cancer study in collaboration with Stanford University

Invitae announces results of hereditary breast cancer study in collaboration with Stanford University

September 07, 2013

Presentation at ASCO Breast Symposium demonstrates that next-generation DNA sequencing technology accurately identifies BRCA 1 and 2 mutations and multi-gene testing adds value beyond BRCA 1 and 2 for cancer patients.

SAN FRANCISCO, CA -  September 07, 2013 -  Invitae, Inc., a genetic information company, today announced the results of a study conducted in collaboration with Stanford University assessing hereditary breast and ovarian cancer risk using a multi-gene next-generation sequencing panel. The results showed that analysis of BRCA1/2 mutations produced ...

Read more


International initiative applauds the Supreme Court decision eliminating gene patents and announces the launch of a public database for hereditary gene mutations

International initiative applauds the Supreme Court decision eliminating gene patents and announces the launch of a public database for hereditary gene mutations

June 13, 2013

SAN FRANCISCO, CA - June 13, 2013 - A consortium of policy makers, advocacy organizations, individuals, academic centers and industry today announced the formation of a first-of-its kind initiative, Free the Data!, to fill the public information gap caused by the lack of available genetic information for the BRCA1 and BRCA2 genes and plans to expand to provide other types of genetic information in open, searchable databases, including the National Center for Biotechnology Information’s database, ClinVar.  The primary founders ...

Read more


Invitae establishes an international subsidiary and state-of-the-art genetic testing facility in Chile, partnership with biotech pioneer, Pablo Valenzuela

Invitae establishes an international subsidiary and state-of-the-art genetic testing facility in Chile, partnership with biotech pioneer, Pablo Valenzuela

May 30, 2013

SANTIAGO, CHILE - May 30, 2013 - Invitae Corporation announced today the establishment of a South American subsidiary, Invitae Chile SpA, and a partnership with biotechnology pioneer, Pablo Valenzuela and the Fundación Ciencia & Vida, to establish a production facility in Santiago, Chile. Dr. Valenzuela is a well-known biotechnology entrepreneur who co-founded Chiron in 1981 and the Fundacion in 1997.

The new entity is being formed to service global markets with genetic information that will inform routine medical practice and influence ...

Read more


Joining forces with Locus Development

Joining forces with Locus Development

August 08, 2012

Genomic Health Announces Second Quarter 2012 Financial Results and Business Progress

  • Product Revenue Increased 13% Compared with Prior Year 
  • Delivered Net Income of $1.8 Million 
  • Began Offering Oncotype DX® Colon Cancer Test for Stage III Patients 
  • Combined Invitae with Locus Development to Create Independent Genetics Company 
  • Conference Call Today at 4:30 p.m. ET 

REDWOOD CITY, Calif., Aug. 8, 2012 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June ...

Read more


Company Formation

Company Formation

February 06, 2012

Genomic Health Announces Formation of New Genetics Subsidiary

REDWOOD CITY, Calif., Feb. 6, 2012 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today announced plans to establish a wholly owned subsidiary with the goal of improving the quality of diagnosis, communication and support for millions of patients and their families faced with common and rare genetic conditions.   The subsidiary is expected to be established by March 1, 2012 and provide its first commercial service in 2013.  The new venture will be ...

Read more